PHASE-III DOUBLE-BLIND RANDOMIZED STUDY OF PIXY321 VERSUS GCSF AFTER CEP FOR BREAST OR OVARIAN-CARCINOMA

Citation
Gk. Ellis et al., PHASE-III DOUBLE-BLIND RANDOMIZED STUDY OF PIXY321 VERSUS GCSF AFTER CEP FOR BREAST OR OVARIAN-CARCINOMA, Blood, 88(10), 1996, pp. 1783-1783
Citations number
NO
Categorie Soggetti
Hematology
Journal title
BloodACNP
ISSN journal
00064971
Volume
88
Issue
10
Year of publication
1996
Part
1
Supplement
1
Pages
1783 - 1783
Database
ISI
SICI code
0006-4971(1996)88:10<1783:PDRSOP>2.0.ZU;2-A